238 related articles for article (PubMed ID: 27240110)
1. Intracranial subdural hematomas with elevated rivaroxaban concentration and subsequently detected spinal subdural hematoma: A case report.
Yamaguchi Y; Koga M; Matsuki T; Hino T; Yokota C; Toyoda K
Thromb Res; 2016 Jul; 143():127-9. PubMed ID: 27240110
[TBL] [Abstract][Full Text] [Related]
2. Non-Traumatic Spontaneous Spinal Subdural Hematoma in a Patient with Non-Valvular Atrial Fibrillation During Treatment with Rivaroxaban.
Castillo JM; Afanador HF; Manjarrez E; Morales XA
Am J Case Rep; 2015 Jun; 16():377-81. PubMed ID: 26090890
[TBL] [Abstract][Full Text] [Related]
3. Nontraumatic spinal subdural hematoma complicating direct factor Xa inhibitor treatment (rivaroxaban): a challenging management.
Dargazanli C; Lonjon N; Gras-Combe G
Eur Spine J; 2016 May; 25 Suppl 1():100-3. PubMed ID: 26228186
[TBL] [Abstract][Full Text] [Related]
4. Acute Spinal Subdural Hematoma in a Patient Taking Rivaroxaban.
Bang WS; Kim KT; Park MK; Sung JK; Lee H; Cho DC
J Korean Med Sci; 2018 Jan; 33(5):e40. PubMed ID: 29349949
[No Abstract] [Full Text] [Related]
5. Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy.
Sholzberg M; Xu Y
JAMA; 2018 Oct; 320(14):1485-1486. PubMed ID: 30242329
[No Abstract] [Full Text] [Related]
6. A case report of parenchymal hematoma after intravenous thrombolysis in a rivaroxaban-treated patient: Is it a true rivaroxaban hemorrhagic complication?
Rota E; Bruzzone G; Agosti S; Pastorino R; Morelli N
Medicine (Baltimore); 2017 Dec; 96(51):e9435. PubMed ID: 29390574
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous Spinal Epidural Hematoma in a Patient on Rivaroxaban: Case Report and Literature Review.
Ismail R; Zaghrini E; Hitti E
J Emerg Med; 2017 Oct; 53(4):536-539. PubMed ID: 29079069
[TBL] [Abstract][Full Text] [Related]
8. Lumbar Subdural Hematoma Detected After Surgical Treatment of Chronic Intracranial Subdural Hematoma.
Fujita T; Iwamoto Y; Takeuchi H; Tsujino H; Hashimoto N
World Neurosurg; 2020 Feb; 134():472-476. PubMed ID: 31756510
[TBL] [Abstract][Full Text] [Related]
9. Do cranial subdural hematomas migrate to the lumbar spine?
Moscovici S; Paldor I; Ramirez de-Noriega F; Itshayek E; Shoshan Y; Spektor S; Attia M
J Clin Neurosci; 2011 Apr; 18(4):563-5. PubMed ID: 21257311
[TBL] [Abstract][Full Text] [Related]
10. Rivaroxaban-associated intracranial hemorrhage in Saudi atrial fibrillation patients.
Alkhotani A; Alrishi N; Alharthi M; Alzahrani W
Medicine (Baltimore); 2020 Nov; 99(48):e23316. PubMed ID: 33235091
[TBL] [Abstract][Full Text] [Related]
11. Acute Intracranial and Spinal Subdural Hematoma Associated with Vardenafil.
Nakamura T; Watanabe G; Harada R; Kawasaki E; Tsukita K; Suzuki Y
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):e201-e202. PubMed ID: 29729844
[TBL] [Abstract][Full Text] [Related]
12. Oral factor Xa inhibitors and risk of subdural hematoma: COMPASS trial results and meta-analysis.
Catanese L; Eikelboom JW; Bosch J; Shestakovska O; Ng K; Nayar S; Perera KS; Shoamanesh A; Sharma M; Hart RG
Neurology; 2020 Aug; 95(5):e480-e487. PubMed ID: 32651298
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
[TBL] [Abstract][Full Text] [Related]
14. Subacute spinal subdural hematoma associated with intracranial subdural hematoma.
Sari A; Sert B; Dinc H; Kuzeyli K
J Neuroradiol; 2006 Feb; 33(1):67-9. PubMed ID: 16528209
[TBL] [Abstract][Full Text] [Related]
15. Prospective assessment of concomitant lumbar and chronic subdural hematoma: is migration from the intracranial space involved in their manifestation?
Kokubo R; Kim K; Mishina M; Isu T; Kobayashi S; Yoshida D; Morita A
J Neurosurg Spine; 2014 Feb; 20(2):157-63. PubMed ID: 24286531
[TBL] [Abstract][Full Text] [Related]
16. Response of prothrombin time to rivaroxaban in Japanese patients with non-valvular atrial fibrillation: Characteristics of 5 representative reagents in Japan (CVI ARO 1).
Suzuki S; Yamashita T; Kasai H; Otsuka T; Sagara K
Thromb Res; 2017 Feb; 150():73-75. PubMed ID: 28043042
[No Abstract] [Full Text] [Related]
17. Concomitant Intracranial Chronic Subdural Hematoma and Spinal Subdural Hematoma: A Case Report and Literature Review.
Matsumoto H; Matsumoto S; Yoshida Y
World Neurosurg; 2016 Jun; 90():706.e1-706.e9. PubMed ID: 26996734
[TBL] [Abstract][Full Text] [Related]
18. Retroperitoneal haematoma in a postoperative ALIF patient taking rivaroxaban for atrial fibrillation.
Deekonda P; Stokes OM; Chan D
Eur Spine J; 2019 Apr; 28(4):688-692. PubMed ID: 27807780
[TBL] [Abstract][Full Text] [Related]
19. Rivaroxaban in the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation: Clinical Implications of the ROCKET AF Trial and Its Subanalyses.
Spencer RJ; Amerena JV
Am J Cardiovasc Drugs; 2015 Dec; 15(6):395-401. PubMed ID: 26062914
[TBL] [Abstract][Full Text] [Related]
20. [Real life clinical management of nonvalvular atrial fibrillation: results from the Italian epidemiological survey eXperience on the use of rivaroxaban].
Colonna P; Ammirati F;
G Ital Cardiol (Rome); 2016 Nov; 17(11):932-939. PubMed ID: 27996999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
